104 related articles for article (PubMed ID: 9854217)
41. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
[TBL] [Abstract][Full Text] [Related]
42. Anemia in patients on combined androgen block therapy for prostate cancer.
Qian LX; Hua LX; Wu HF; Sui YG; Cheng SG; Zhang W; Li J; Wang XR
Asian J Androl; 2004 Dec; 6(4):383-4. PubMed ID: 15546035
[TBL] [Abstract][Full Text] [Related]
43. Pneumonitis and non steroidal antiandrogens.
Prescrire Int; 2003 Aug; 12(66):141. PubMed ID: 12908492
[TBL] [Abstract][Full Text] [Related]
44. The role of intermittent androgen deprivation in prostate cancer.
Boccon-Gibod L; Hammerer P; Madersbacher S; Mottet N; Prayer-Galetti T; Tunn U
BJU Int; 2007 Oct; 100(4):738-43. PubMed ID: 17662079
[No Abstract] [Full Text] [Related]
45. Flutamide induced lupus.
Reid MB; Glode LM
J Urol; 1998 Jun; 159(6):2098. PubMed ID: 9598538
[No Abstract] [Full Text] [Related]
46. Effect of flutamide on survival in patients with pancreatic cancer. Results are impressive.
Wigmore SJ; Fearon KC; Garden OJ
BMJ; 1999 Jan; 318(7179):327; author reply 328. PubMed ID: 10075463
[No Abstract] [Full Text] [Related]
47. [The hepatotoxicity of flutamide].
Pogromov AP; Popova AM
Klin Med (Mosk); 1998; 76(7):56-8. PubMed ID: 9742783
[No Abstract] [Full Text] [Related]
48. Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.
Boudreaux KJ; Chang SS
BJU Int; 2008 Mar; 101(6):671-4. PubMed ID: 18070172
[No Abstract] [Full Text] [Related]
49. A review of the use of histrelin acetate in the treatment of prostate cancer.
Crawford ED
BJU Int; 2009 Mar; 103 Suppl 2():14-22. PubMed ID: 19228148
[No Abstract] [Full Text] [Related]
50. [Toxic hepatitis caused by flutamide].
Cuevas Campos MA; Pareja Llorens G; García Romero E; Bertomeu Blanch F
Gastroenterol Hepatol; 1998 Dec; 21(10):499-500. PubMed ID: 9927799
[No Abstract] [Full Text] [Related]
51. Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy.
J Support Oncol; 2006 Feb; 4(2):99-100. PubMed ID: 16499137
[No Abstract] [Full Text] [Related]
52. Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10.
Shipley WU; Desilvio M; Pilepich MV; Roach M; Wolkov HB; Sause WT; Rubin P; Lawton CA
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1162-7. PubMed ID: 16427211
[TBL] [Abstract][Full Text] [Related]
53. [Toxic hepatitis caused by flutamide and hirsutism].
Román Llorente FJ; Alvarez Navascués C; Suárez González A; González Bernal AC
Gastroenterol Hepatol; 2000 May; 23(5):258. PubMed ID: 10902281
[No Abstract] [Full Text] [Related]
54. Fulminant liver failure associated with flutamide therapy for hirsutism.
Andrade RJ; Lucena MI; Fernández MC; Suárez F; Montero JL; Fraga E; Hidalgo F
Lancet; 1999 Mar; 353(9157):983. PubMed ID: 10459914
[No Abstract] [Full Text] [Related]
55. Prostate cancer drugs. Making sense of the options.
Mayo Clin Health Lett; 2003 Aug; 21(8):4-5. PubMed ID: 12971308
[No Abstract] [Full Text] [Related]
56. Flutamide-induced pseudoporphyria.
Borroni G; Brazzelli V; Baldini F; Borghini F; Gaviglio MR; Beltrami B; Nolli G
Br J Dermatol; 1998 Apr; 138(4):711-2. PubMed ID: 9640390
[No Abstract] [Full Text] [Related]
57. Photosensitive dermatitis induced by flutamide.
Fujimoto M; Kikuchi K; Imakado S; Furue M
Br J Dermatol; 1996 Sep; 135(3):496-7. PubMed ID: 8949460
[No Abstract] [Full Text] [Related]
58. [Liver toxicity associated with flutamide].
Vázquez Romero M; Gil Grande L; López Serrano P; Alemán Villanueva S; García Plaza A
An Med Interna; 2004 Jun; 21(6):307-8. PubMed ID: 15283649
[No Abstract] [Full Text] [Related]
59. Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
Gardiner RA; Nicol DL; Green HJ; Yaxley J; Watson R; Mactaggart P; Headley BC; Swanson C; Pakenham KI
J Urol; 2004 Aug; 172(2):774; author reply 774-5. PubMed ID: 15247782
[No Abstract] [Full Text] [Related]
60. Fatal liver complications with flutamide.
Osculati A; Castiglioni C
Lancet; 2006 Apr; 367(9517):1140-1. PubMed ID: 16616550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
